JP2021526370A5 - - Google Patents

Info

Publication number
JP2021526370A5
JP2021526370A5 JP2020564893A JP2020564893A JP2021526370A5 JP 2021526370 A5 JP2021526370 A5 JP 2021526370A5 JP 2020564893 A JP2020564893 A JP 2020564893A JP 2020564893 A JP2020564893 A JP 2020564893A JP 2021526370 A5 JP2021526370 A5 JP 2021526370A5
Authority
JP
Japan
Prior art keywords
containing seq
probe
primer containing
patient
detecting
Prior art date
Application number
JP2020564893A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019226942A5 (https=
JP2021526370A (ja
JP7637509B2 (ja
Filing date
Publication date
Priority claimed from CN201810502359.7A external-priority patent/CN108660209B/zh
Priority claimed from CN201810502387.9A external-priority patent/CN108676878B/zh
Application filed filed Critical
Priority claimed from PCT/US2019/033831 external-priority patent/WO2019226942A1/en
Publication of JP2021526370A publication Critical patent/JP2021526370A/ja
Publication of JPWO2019226942A5 publication Critical patent/JPWO2019226942A5/ja
Publication of JP2021526370A5 publication Critical patent/JP2021526370A5/ja
Application granted granted Critical
Publication of JP7637509B2 publication Critical patent/JP7637509B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020564893A 2018-05-23 2019-05-23 大腸がんおよび進行腺腫をスクリーニングするためのキットおよびその応用 Active JP7637509B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201810502359.7A CN108660209B (zh) 2018-05-23 2018-05-23 基于bmp3基因甲基化制备结直肠癌早期检测的产品
CN201810502387.9 2018-05-23
CN201810502387.9A CN108676878B (zh) 2018-05-23 2018-05-23 检测ndrg4基因甲基化位点的产品在制备结直肠癌早期检测的产品的用途
CN201810502359.7 2018-05-23
PCT/US2019/033831 WO2019226942A1 (en) 2018-05-23 2019-05-23 The kit for screening colorectal cancer and advanced adenoma and its application

Publications (4)

Publication Number Publication Date
JP2021526370A JP2021526370A (ja) 2021-10-07
JPWO2019226942A5 JPWO2019226942A5 (https=) 2022-05-30
JP2021526370A5 true JP2021526370A5 (https=) 2022-05-30
JP7637509B2 JP7637509B2 (ja) 2025-02-28

Family

ID=68617194

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020564893A Active JP7637509B2 (ja) 2018-05-23 2019-05-23 大腸がんおよび進行腺腫をスクリーニングするためのキットおよびその応用

Country Status (10)

Country Link
US (1) US20210207221A1 (https=)
EP (1) EP3797112A4 (https=)
JP (1) JP7637509B2 (https=)
KR (1) KR20210035094A (https=)
CN (1) CN112752763B (https=)
AU (1) AU2019275073A1 (https=)
BR (1) BR112020023274A2 (https=)
CA (1) CA3098028A1 (https=)
SG (1) SG11202010208YA (https=)
WO (1) WO2019226942A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113699237A (zh) * 2020-07-29 2021-11-26 上海吉凯医学检验所有限公司 一种检测早期结直肠癌和腺瘤的dna甲基化标志物的试剂盒

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541308A (en) * 1986-11-24 1996-07-30 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
EP1942197A1 (de) * 2000-09-01 2008-07-09 Epigenomics AG Verfahren zur Bestimmung des Methylierungsgrades von bestimmten Cytosinen in genomischer DNA im Sequenzkontext 5'-CpG-3'
DE10112515B4 (de) * 2001-03-09 2004-02-12 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität
CN103649298A (zh) * 2011-05-12 2014-03-19 精密科学公司 核酸的分离
WO2013142545A1 (en) * 2012-03-20 2013-09-26 Exact Sciences Corporation Marker panel for detecting cancer
EP4234722A3 (en) * 2014-03-31 2023-09-20 Mayo Foundation for Medical Education and Research Detecting colorectal neoplasm
WO2016094839A2 (en) * 2014-12-12 2016-06-16 Exact Sciences Corporation Compositions and methods for performing methylation detection assays
ES2879964T3 (es) * 2014-12-12 2021-11-23 Exact Sciences Dev Co Llc Composiciones y métodos para realizar ensayos de detección de metilación
CN104975110A (zh) * 2015-06-02 2015-10-14 浙江诺辉生物技术有限公司 用于检测生物样本中bmp3和ndrg4甲基化水平的引物和探针
AU2016343937B2 (en) * 2015-10-30 2023-01-19 Exact Sciences Corporation Multiplex amplification detection assay and isolation and detection of DNA from plasma
WO2018087129A1 (en) * 2016-11-08 2018-05-17 Region Nordjylland, Aalborg University Hospital Colorectal cancer methylation markers
CN106399570A (zh) 2016-11-30 2017-02-15 杭州诺辉健康科技有限公司 用于早期结直肠癌辅助诊断的试剂盒及其使用方法和检测系统

Similar Documents

Publication Publication Date Title
Lamy et al. Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls
US9556491B2 (en) Utility of B-RAF DNA mutation in diagnosis and treatment of cancer
Siravegna et al. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Bax et al. Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development
Morlan et al. Mutation detection by real-time PCR: a simple, robust and highly selective method
US20260062759A1 (en) Consensus coding sequences of human breast and colorectal cancer
Watanabe et al. Heterogeneity of KRAS status may explain the subset of discordant KRAS status between primary and metastatic colorectal cancer
Aung et al. Analytical validation of BRAF mutation testing from circulating free DNA using the amplification refractory mutation testing system
US20150057275A1 (en) Methods and materials for genetic analysis of tumors
Akca et al. Utility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancer
Beau-Faller et al. Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping
WO2011126768A2 (en) Methods and materials for detecting colorectal cancer and adenoma
CN106939337B (zh) 激素受体阳性乳腺癌复发监测基因突变文库的构建方法
Kobunai et al. The frequency of KRAS mutation detection in human colon carcinoma is influenced by the sensitivity of assay methodology: a comparison between direct sequencing and real-time PCR
WO2017112738A1 (en) Methods for measuring microsatellite instability
Seki et al. Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
Nordgård et al. Comparison of a PNA clamp PCR and an ARMS/Scorpion PCR assay for the detection of K-ras mutations
Araki et al. Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon12 mutations in lung adenocarcinoma: Comparison of PNA-clamp SmartAmp2 and PCR-related methods
CN111583999B (zh) 建立检测微卫星不稳定的基线的方法、装置及应用
CN111587292A (zh) 用于检测癌症相关突变的试剂盒和方法
Carbonell et al. Comparison of allelic discrimination by dHPLC, HRM, and TaqMan in the detection of BRAF mutation V600E
Chen et al. Lymph node metastases of melanoma: challenges for BRAF mutation detection
JP2021526370A5 (https=)
CN115094139B (zh) 检测甲基化水平的试剂在制备膀胱癌诊断产品中的应用以及膀胱癌诊断试剂盒
Sahnane et al. Pyrosequencing for EGFR mutation detection: diagnostic accuracy and clinical implications